Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration.
Status:
Recruiting
Trial end date:
2024-09-30
Target enrollment:
Participant gender:
Summary
The goal of this study is to compare the difference in clinical pregnancy, miscarriage and
livebirth rate between day 6 euploid blastocyst transfer on the 6th and the 7th day of
progesterone exposure in Hormonal Replacement Therapy (HRT) FET cycles. This prospective &
randomized study will only include euploid day 6 blastocysts. This will be the first
prospective study of euploid day 6 blastocysts thereby excluding aneuploidy as a cause of
miscarriage and implantation failure. The point of randomization will occur on the day of
progesterone commencement.